News

UK Biotech & Life Sciences News

Follow the latest UK life sciences company news, including biotech funding rounds, pharma partnerships, product launches, clinical updates, infrastructure projects and commercial announcements.

Latest updates
Showing 13–24 of 243 stories

TRIMTECH Therapeutics Signs Biogen Degrader Deal Worth Up to $411m

TRIMTECH Therapeutics has signed a research collaboration, option and licence agreement with Biogen to develop small molecule protein degraders for neurodegenerative diseases. Payments could total up to $411m plus royalties, including up to $32m in combined upfront and research milestone payments, and Biogen holds an option on a global exclusive licence.

Funding & Grants12 Nov 2026

Wellcome Sanger Researchers Join Two €10m ERC Synergy Grant Projects

Two international research teams involving Wellcome Sanger Institute scientists have each secured a €10m European Research Council Synergy Grant for six-year projects. Jussi Taipale co-leads FIBERMAP, which will investigate genome regulation in healthy tissue and tumours, while Muzlifah Haniffa co-leads DevSkin, which will map human skin development and support the creation of region-specific skin organoids. The €20m is the combined value of the two consortium awards, not funding allocated solely to Sanger.